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Several studies have shown an increased risk for infection and 
cancer in alcoholic patients. The mechanisms for such observations 
remain largely unknown. In an effort to investigate the possibility of 
immunological dysfunction In alcoholism, we studied three immune 
parameters in 47 hospitalized chronic alcoholic patients and 47 age- 
and sex-matched normal controls. The immune measures were: (1) 
lymphocyte phenotyping, with estimates of percentages of T cells, 
B cells, T helpers, T suppressors, natural killer (NK) cells, and cells 
carrying the activation markers IL2R1 and 12; (2) NK cell activity; and 
(3) lymphokine-activated killer cell activity. Results indicate a signif- 
icant increase in the IL2R and l2 lymphocyte markers in alcoholic 
patients compared with matched controls. We also found a nonsig- 
nificant trend for a decrease in the percentage of suppressor T cells 
in the alcoholic group, as well as a trend for a negative correlation 
between the percentage of T suppressor cells and age. There were 
no significant differences in either NK or lymphokine-activated killer 
cell activities between the two groups. Furthermore, there were no 
significant associations between duration and intensity of alcohol 
consumption and any of the immune measures. These results sug- 
gest subtle alterations in immune regulation in alcoholic patients that 
cannot be explained solely on the basis of duration and/or amount 
of alcohol consumed. 
Key Words: Alcohol, Immunity, Lymphocyte Phenotype, Lympho- 
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EVERAL REPORTS have indicated an increased risk S of infection and cancer in alcoholic patients.'-3 Al- 
though the mechanisms for such an association remain 
largely unknown, a reasonable assumption has been that 
alcohol impairs the immune system and weakens the 
host's defense mechanisms, thus increasing the risk of 
infection and cancer in otherwise predisposed individuals. 
Research on the effects of alcohol on the immune system 
however has yielded mixed results. In vitro studies seem 
to indicate that alcohol at lower concentrations may ac- 
tually enhance natural killer (NK) a~t iv i ty .~ ,~  At higher 
concentrations, the effects of alcohol are uniformly im- 
munos~ppressive.~.~ Results from animal studies have 
similarly shown both enhancement and suppression of 
different immunological parameters. Bagasra et al.* found 
elevated plaque-forming cells and antibody responses to 
antigens in alcohol-fed animals compared with matched 
controls. This immunnoenhancement, however, turned 
into immunosuppression as the duration of ethanol inges- 
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tion increased. Other investigators have shown either an 
increa~e,~ no change," or a decrease"," in NK activity in 
alcohol-consuming animals compared with controls. Hu- 
man studies are relatively few, and possible confounding 
variables are many. Charpentier et a1.I3 found an impair- 
ment in lymphocyte NK cell activity in chronic alcoholics, 
but only in those with active liver cirrhosis, and particu- 
larly those with severe malnutrition. Irwin et al.I4 con- 
firmed the reduction in NK activity in alcoholics, even in 
those without evidence of liver cirrhosis or malnutrition, 
but found no clear relation with the amount of alcohol 
consumed. Saxena et al.,I5 on the other hand, reported 
increased NK activity in lymphocytes from alcoholic sub- 
jects in spite of nutritional deficiencies and other drug 
addictions. Other studies have shown that immune param- 
eters, including NK activity, were not significantly differ- 
ent in alcoholic patients and normal controls.I6 
In this study, we report our immunological findings on 
hospitalized chronic alcoholic patients and age- and sex- 
matched normal controls. Patients and control were given 
several immunological tests, including lymphocyte phe- 
notyping with monoclonal antibodies and functional as- 
says of both NK and lymphokine-activated killer (LAK) 
cell activities. Both patients and controls were also given 
extensive clinical and demographic assessments, with em- 
phasis on duration and quantity of alcohol use. 
METHODS 
Subjects for the study were 47 alcoholic patients and 47 age- and sex- 
matched normal controls. All alcoholic patients were screened by the 
University of Michigan Alcohol Research Center and were hospitalized 
at one of the University of Michigan alcohol treatment facilities. Screen- 
ing by the Alcohol Research Center was done by trained personnel and 
consisted of an extensive evaluation of clinical and demographic features, 
with special emphasis on drinking behavior. Each patient was age- and 
sex-matched with a normal control. Both patients and controls were 
evaluated with a structured psychiatric interview, the Diagnostic Inter- 
view Schedule," from which a DSM-III-R'8 diagnosis was made. All 
patients met DSM-111-R criteria for alcohol abuse and/or dependence as 
reflected in the Diagnostic Interview Schedule interview. No other psy- 
chiatric diagnosis was made. None of the normal controls met criteria 
either past or present for any psychiatric diagnosis. Both patients and 
controls were relatively healthy and free of severe medical illness known 
to interfere with immune regulation. Illnesses that were considered 
exclusionary criteria included cancer, systemic infection, stroke, insulin- 
dependent diabetes mellitus, liver cirrhosis, and the like. Thirteen patients 
were drug-free. The remainder were taking one or more pharmacological 
agents, including psychotropic medications. Immune-related medica- 
tions, such as antiinfectious and antiinflammatory medications, were not 
allowed. Drinking severity was assessed with estimates of lifetime average 
drinks per day and years of heavy drinking. Mood states were rated with 
the Hamilton Rating Scale for Depression (HRSD)I9 and the Profile of 
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Mood States (POMS)." In addition, severity of life events was assessed 
with the Holmes and Rahe life events schedule2' and a line scale for the 
perception of stress.Zz 
Lymphocyte Separation 
Blood samples from both patients and age- and sex-matched normal 
controls were drawn between 8:OO and 9:00 in the morning in heparinized 
tubes. Lymphocytes were separated by a mo&fied method of B o y ~ m . ~ ~  
Blood was diluted with an equal volume of phosphate-buffered saline 
(PBS) and centrifuged at 400 X g for 30 min at room temperature over 
a cushion of Ficoll-Hypaque solution. The mononuclear cells were then 
harvested, washed three times with PBS, and resuspended in RPMI 1640 
medium containing 25 mM HEPES buffer supplemented with 10% heat- 
inactivated fetal calf serum (Gibco, Grand Island, NY), 80 pglml genta- 
micin (Schering Corp., Kenilworth, NJ), and 300 gg fresh glutamine/ml 
(complete medium). Mononuclear cells were depleted of adherent mono- 
cytes by passage over a column of Sephadex G-10 beads (Pharmacia Fine 
Chemicals, Piscataway, NJ) equilibrated in the same complete medium. 
The cell recovery was >70% of the total input, and monocyte contami- 
nation as indicated by nonspecific esterase staining was <2%. 
Lymphocyte Phenotyping 
For the lymphocyte phenotyping, lo6 lymphocytes from each subject 
and matched control were washed and incubated separately with the 
following commercially available monoclonal antibodies (Coulter Im- 
munology, Hialeah, FL): CD2 (total T cells), CD4 (helper/inducer T 
cells), CDs (suppressor/cytotoxic T cells), CDZo (total B cells), CD56 (NK 
cells), and the activation markers ILzRl (defining the receptor for inter- 
leukin-2) and Iz (an HLA-D/DR related Ia-like antigen). In addition to 
these monoclonal antibodies, a negative control of mouse IgG was used 
to provide a baseline for flow cytometry. The cells were incubated with 
10 pl of the respective monoclonal antibodies at 4°C for 30 min. Follow- 
ing incubation the cells were washed three times with MEM medium 
containing 2% fetal calf serum and then fixed with 1 % formalin in PBS. 
The labeled and fixed cells were later analyzed by flow cytometry with 
the fluorescein-activated cell sorter (EPICS), a core facility at the Uni- 
versity of Michigan Medical Center. 
Assay of NK Activity 
NK activity was determined in a direct V r  release assay as previously 
de~cribed.2~ Briefly, a fixed number of viable effector cells were prepared 
in varying dilutions to give 5 0  1,25: 1,12.5: 1,6.25:1, and 3.125: 1 effector 
to target (ET) cell ratios. Effector cells were added to triplicate cultures 
of slCr-labeled target cells (K562 cell line) in a final volume of 0.2 ml in 
V bottom microtiter plates (Dynatech Labs, Alexandria, VA). After 
centrifugation at 40 X g for 5 min, they were incubated at 37'C in a 
humidified atmosphere of 5% C02 in air for 4 hr. At the end of 
incubation, plates were spun at 400 x g for 5 min, and 100 fil aliquots 
of supernatants were removed from each well and transferred to glass 
tubes to be read in a Packard model 593 gamma counter. Percentage of 
cytotoxicity was calculated as follows: 
experimental release - spontaneous release 
total release - spontaneous release % cytotoxicity = x 100, 
where spontaneous release represents count released from control wells 
containing only 1 x lo4 target cells. Cytotoxicity is also expressed as lytic 
units (LUs) per lo' effector cells. A LU is defined as the number of 
effector cells needed to yield 30% cytotoxicity of 1 x lo4 target cells. 
LUs are calculated from the cytotoxicity curve for each test by linear 
regression analysis as described.25 
Assay of LAK Cell Activity 
LAK cell activity assays were performed as described.% Briefly, a fixed 
number of cells from the lymphocyte preparation was incubated for 5 
days in a complete medium to which 10 units/ml of human recombinant 
interleukin-2 (Collaborative Biomedical Products, Inc., Lexington, MA) 
was added to generate LAK cells. LAK cell cytotoxicity was then assessed 
using a standard 4-hr "Cr release assay against SB, an NK-resistant 
human leukemia B cell line. A control culture that was not treated with 
IL-2 produced 4% of total 5'CR release.26 Results are expressed as 
percentage of cytotoxicity, as with the NK assays. 
Statistical Analvsis 
The primary data analysis compared patients and their matched 
control subjects on demographic, clinical, and immunological measures 
(lymphocyte phenotyping, NK and LAK cell activities). Paired t tests 
were used for all of these comparisons, with a Bonferroni correction for 
multiple tests, where indicated. Differences in NK activity were analyzed 
with paired t tests both on the individual percentage cytotoxicities for 
each E T  ratio, as well as on the natural logarithm of the LU calculated 
with a SAS NLIN program courtesy of Dr. Eda LAK cell 
activity was tested by paired t test on the percentage of cytotoxicity for 
the four different E T  ratios used. Variables expressed as percentages 
were reanalyzed after arcsin transformation. Transformation made no 
appreciable difference in the analysis results; therefore, nontransformed 
results are presented herein, except for the case of NK LUs. Pearson 
correlation coefficients were calculated between clinical variables and the 
immunological measures that differed between patients and their 
matched controls. 
Numbers of patient-control pairs varied for lymphocyte phenotyping 
and other laboratory tests. Although 47 pairs were studied, accurate LU 
measures for the NK assay were available for 42 pairs. LAK cell assays 
were available for 11 pairs. Most lymphocyte subsets were available for 
36 pairs, but I2 and IL2RI were added later and are presented here for 15 
pairs only. 
RESULTS 
Demographic and clinical features for both the alcoholic 
patients and the normal controls are presented in Table 
1. There were no significant differences in either age or 
sex distribution, because patients were age- and sex- 
matched with normal controls. As expected, the alcoholic 
patients had a significantly higher average number of 
drinks per day ( t  = 7.653; p < 0.0001); they also had a 
significantly longer duration of heavy drinking ( t  = 6.997; 
p < 0.0001). There were, however, no significant differ- 
ences in days since last drink between alcoholic patients 
and their matched controls ( t  = -1.663; p > 1.0). Fur- 
thermore, alcoholic patients scored significantly higher on 
the HRSD ( t  = 4.525; p < 0.0001) and the POMS depres- 
sion subscale ( t  = 4.980; p < 0.0001). They also reported 
Table 1. Demographic and Clinical Features in Alcoholic Patients and Normal 
Controls 
Alcoholic Normal 
(ff = 47) (ff = 47) 
Van'able patients controls Significance 
Age 
sex (M/F) 
LBetirne average drinks/day 
Years heavy drinking 




50.6 f 12.9 
3918 
7.5 + 4.0 
12.3 f 10.7 
5.7 f 5.1 
4.7 f 5.4 
13.7 f 13.4 
187.7 f 132 
51.9 f 12.3 
3918 
1.8 f 0.9 
o + o  
12.4 f 24.6 
0.4 f 1.2 
2.5 f 4.0 









Results are expressed as mean f SD. NS. not statistically significant. 
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significantly more stressful life events ( t  = 3.493; p < 
0.0001), as reflected by their scores on the Holmes and 
Rahe scales. 
Results of the lymphocyte phenotyping are presented in 
Table 2. There were no significant differences in the 
percentage of T cells, B cells, or NK cells between the two 
groups. There was a suggestion that alcoholic patients may 
have a lower percentage of suppressor cells CD8 ( t  = 1.923; 
p = 0.063), and a trend toward higher helper-suppressor 
T cell ratios CD4/CD8 ( t  = 1.989; p = 0.0545). Further, 
we found significantly higher percentages of lymphocytes 
carrying the activation markers ILzRl ( t  = -2.599; p = 
0.022) and significantly higher percentages of lymphocytes 
carrying the activation marker Iz ( t  = -3.422; p = 0.005) 
in alcoholic patients compared with their matched con- 
trols. 
Figure 1 shows the results of the fimctional assays 
comparing NK activity between the alcoholic patients and 
their matched controls. Differences in percentage cytotox- 
icity between the two groups were not statistically signifi- 
cant for any of the E:T ratios used. The corresponding t 
Table 2. Lymphocyte Subsets in Alcohol Patients and Normal Controls 
Lymphocyte marker 
C D ~  (total n 61.2 f 14.8 63.3 + 13.9 NS 
and p values for the 5 E:T ratios were t = 0.406, p = 0.688; 
t = 0.492, p = 0.626; t = 0.26 1, p = 0.795; t = 0.199, p = 
0.843 and t = 0.289, p = 0.774, respectively. Similarly, no 
significant differences were found when the results were 
expressed in LUs ( t  = -0.412, p = 0.683). 
Comparisons of LAK cell activities between alcoholic 
patients and matched controls are shown in Fig. 2. Here 
again, there were no significant differences between the 
two groups for any of the E:T ratios examined. Corre- 
sponding t and p values for the 4 E:T ratios were t = 
= 0.323; and t = -1.455, p = 0.206, respectively. 
Because age has often been found to correlate negatively 
with different immune variables, we examined the poten- 
tial effects of age on the distribution of the different 
lymphocyte subsets, as well as the effects of age on both 
NK and LAK cell activities. There were no significant 
associations between patient age and any of the immune 
variables studied. We did, nevertheless, find a nonsignifi- 
cant negative association between age and CD8 (Y  = 
-0 .289;~  = 0.087) in the alcoholic patients but not among 
the control subjects. There were also no significant differ- 
ences in immune measures between medicated and un- 
medicated patients. Furthermore, there were no significant 
associations between CDs, IL2RI or I2 and any of the 
-0.706, p = 0.495; t = -0.745, p = 0.469; t = -1.035, p 
~. ~ ~. 
CD4 (l help&/inducer) 41.1 k 13.6 40.9 f 12.1 NS 
2,6*  1,8 o,9 o.0545 normal controls (data not shown). 
clinical variables in either the alcoholic patients or the 
CDs (T supressor/cytotoxic) 20.2 f 8.8 24.2 f 9.4 0.063 
CDdlCDa 
CD, (total B) 7.6 k 5.9 6.3 f 4.1 NS 
CDas (NK cells) 11.8*7.6 12.3?10.0 NS DISCUSSION IL& (interleukin-2 receptor) 9.0 k 4.5 5.5 + 3.0 0.022 
l2 (HLA-D/DR-related la-like antigen) 15.6 * 4.8 9.6 f 4.1 0.005 This study was undertaken to assess key immune pa- 










W Normal Controls 
Alcoholic Patients 
12.5:1 6.25 1 3.1291 
E T  Ratios E T  Rsticw 
Fig. 1. Lymphocyte NK cell activity in alcoholic patients and matched normal 
controls. Results are expressed in percentage cytotoxicity (mean 2 SE) against 
K562 cells for the different E:T ratios used. No significant differences between 
patients and controls were observed. 
Fig. 2. LAK cell activity in alcoholic patients and matched normal controls. 
Results are expressed in percentage cytotoxicity (mean f SE) against the NK- 
resistant SB cells for the different E:T ratios used. No significant differences 
between patients and controls were observed. 
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pared with age- and sex-matched normal controls. The 
immunological assessment included lymphocyte pheno- 
typing with monoclonal antibodies representing the major 
lymphocyte subsets (T cells, B cells, NK cells, T helpers, 
and T suppressors), as well as the activation markers ILzR, 
and Iz. In addition to the lymphocyte phenotyping, the 
immunological assessment included two functional assays: 
NK and LAK cell activities. Each patient was age- and 
sex-matched with a normal control, and all immune assays 
were performed simultaneously on fresh blood samples 
from patients and their respective controls to minimize 
the potential effects of interassay variation. In addition, 
we collected extensive demographic and clinical data, 
including potential confounding variables, such as depres- 
sion and stress on both patients and controls. 
Results of the specific lymphocyte subsets show no 
significant differences between alcoholic patients and 
matched normal controls. Similarly, there were no signif- 
icant differences between these two groups in either NK 
or LAK cell activities. These data are consistent with 
previously published reports.I6 Our data also reveal no 
significant associations between patient age and any of the 
immune variables under investigation. There was, how- 
ever, a nonsignificant trend for a negative association 
between age and the percentage of T suppressor cells in 
alcoholic patients but not in controls. Again, these findings 
are consistent with published reports suggesting a decline 
in several immune parameters with age, but not necessar- 
ily in CD4/CDg ratios2’ or NK activity.28 
Our results also indicate a significant increase in the 
activation markers IL2RI and Iz among alcoholic patients 
compared with matched normal controls. This activation 
seems to be independent of the duration of drinking, 
amount of alcohol consumed, or time elapsed since last 
drink. Alcoholic patients were also significantly more de- 
pressed, and experienced significantly more stressful life 
events, but there were no significant associations between 
either IL2RI or I2 and HRSD scores, POMS depression 
scores, or Life Events scores (data not shown). Alcoholic 
patients may also suffer from a variety of medical prob- 
lems, including nutritional deficiencies and liver disease. 
In this study, however, patients with malnutrition or se- 
vere liver disease, including liver cirrhosis, were excluded. 
Patients with other serious medical illness were also ex- 
cluded. It is therefore possible that the use of alcohol may 
activate certain types of lymphocytes resulting in a larger 
number of lymphocytes in alcoholic patients expressing 
the activation markers IL2RI or 12. It is also possible that 
a defect may arise in the binding of the monoclonal 
antibodies to the ILzRl and 12 in the alcoholic patients 
resulting in nonspecific and therefore increased binding to 
these antibodies. Still another possibility is that the alco- 
holic patients may express increased activation antigens 
in response to nonspecific insults to the immune system 
possibly related to subclinical inflammation or infection 
associated with alcoholism. Further research needs to be 
conducted to consider these possibilities. 
In summary, we have compared lymphocyte phenotyp- 
ing, NK and LAK cell activities in a group of hospitalized 
chronic alcoholic patients and individually matched age- 
and sex-matched normal controls. Alcoholic patients had 
a significant increase in the percentage of the activation 
markers IL2R1 and 12. There were, however, no significant 
differences in either NK or LAK cell activities between 
the two groups. These studies suggest subtle alterations in 
immune regulation in alcoholic patients compared with 
matched controls. The clinical significance of these obser- 
vations remains to be determined. 
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